🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Alcoholic Cirrhosis

Faecal Microbiota Transplantation for Liver Cirrhosis NCT04932577Phase 2, Phase 31 site📍 Aarhus University of Aarhus · Tests: Faecal microbiota transplantation, Placebo Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH) NCT05870969n/a1 site📍 Shanghai Ruijin Hospital · Tests: Liver cancer surveillance every 3 months, Liver cancer surveillance every 6 months, Liver cancer surveillance annually Liver Damage and Cardiometabolic Disorders in NAFLD NCT04036357n/a1 site📍 Rome University of Roma La Sapienza Digital Early Warning System for Acute Lung Injury in Liver Surgery NCT07070362n/a4 sites📍 Beijing📍 Beijing📍 Chongqing Beijing Tsinghua Chang Gung Hospital A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH NCT06920043Phase 230 sites📍 Chandler📍 Mesa📍 Tucson GlaxoSmithKline · Tests: Efimosfermin, Placebo Cardiac Dysfunction in Patients with Fatty Liver Disease NCT06386094n/a1 site📍 Chandigarh Post Graduate Institute of Medical Education and Research, … · Tests: Echocardiographic assessment The Liver Care Trial NCT05855031NA2 sites📍 Køge📍 Roskilde Zealand University Hospital · Tests: Transient Elastography The European NAFLD Registry NCT04442334n/a37 sites📍 Antwerp📍 Helsinki📍 Angers Newcastle University Comparison Between the Efficacy of Residential and Ambulatory Weight Loss Programs for Pediatric Non-alcoholic Fatty Liver Disease NCT05309863n/a3 sites📍 Ghent📍 Ghent📍 De Haan University Hospital, Ghent · Tests: Lifestyle management A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis NCT06461208Phase 323 sites📍 Basildon📍 Bournemouth📍 Bristol King's College London · Tests: Encapsulated FMT, Placebo Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial NCT06138821NA2 sites📍 Boston📍 Morgantown Pichamol Jirapinyo, MD, MPH · Tests: ESG + lifestyle modification, Lifestyle modification Screening At-risk Populations for Hepatic Fibrosis With Non-invasive Markers NCT03308916NA1 site📍 Odense Maja Thiele · Tests: transient elastography, Enhanced liver fibrosis test, Indirect serum markers of liver fibrosis, Direct serum markers of… Integrated Diagnostics for Early Diagnosis of Liver Disease NCT04666402n/a1 site📍 Manchester Manchester University NHS Foundation Trust · Tests: Blood tests for Single Nucleotide Polymorphisms, Faecal microbiome analysis, Serum for diagnostic biomarkers Automated Passive Case-Finding for Advanced Liver Fibrosis in MASLD: The LiverSeek Programme NCT07658755n/a1 site📍 Madrid Hospital General Universitario Gregorio Marañon Efficacy of Simvastatin in Alcoholic Liver Fibrosis NCT04971577Phase 2, Phase 31 site📍 Barcelona Anna Cruceta · Tests: Simvastatin 40mg InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer NCT05463796n/a1 site📍 Boston Dana-Farber Cancer Institute · Tests: Samples LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis NCT06632444Phase 3531 sites📍 Birmingham📍 Peoria📍 Scottsdale Boehringer Ingelheim · Tests: Survodutide, Placebo European Paediatric Non-Alcoholic Fatty Liver Disease Registry (EU-PNAFLD) NCT04190849n/a3 sites📍 Maastricht📍 Cambridge📍 Birmingham Cambridge University Hospitals NHS Foundation Trust Blood Collection Biorepository for Liver Disease Research NCT03025074n/a1 site📍 Buffalo State University of New York at Buffalo Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB) NCT06599918Phase 21 site📍 Barcelona Fundació Institut de Recerca de l'Hospital de la Santa Creu… · Tests: Nicotinamide, Placebo A Randomized Controlled Study Evaluating Bariatric Surgery as a Treatment for Severe NASH With Advanced Liver Fibrosis in Non-severe Obese Patients NCT03472157NA1 site📍 Lille University Hospital, Lille · Tests: Lifestyle therapy, Bariatric surgery Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans NCT05526144Phase 21 site📍 Columbia VA Office of Research and Development · Tests: Synthroid, Placebo Digoxin In NASH (CODIN) NCT06588699Phase 22 sites📍 New Haven📍 New Haven Yale University · Tests: Digoxin, Placebo Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease NCT07265544n/a1 site📍 Guangzhou Nanfang Hospital, Southern Medical University · Tests: Collection of Preoperative Peripheral Blood, Collection of Discarded Liver Tissue During Surgery Role of the Very Low Calorie Ketogenic Diet (VLCKD) in Patients With Non-Alcoholic Steatohepatitis (NASH) With Fibrosis NCT06308757NA1 site📍 Bologna University of Bologna · Tests: Very-low-calorie ketogenic diet (VLCKD) with meal replacements, Mediterranean low-calorie diet (LCD) Establishment of NAFLD Cohort and Development of Fibrosis Markers NCT02206841n/a1 site📍 Seoul Seoul National University Boramae Hospital · Tests: Liver biopsy, ARFI, SWE, Transient elastography Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD NCT05644717Phase 41 site📍 Peshawar Getz Pharma · Tests: Ertugliflozin 5 mg, 15mg Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States NCT05832229Phase 213 sites📍 La Jolla📍 Los Angeles📍 Los Angeles National Institute of Diabetes and Digestive and Kidney Dis… · Tests: Rosuvastatin PROtocol of Metabolic and Cryptogenic livEr Disease regisTry for intEgration of Omic Studies NCT04371042n/a1 site📍 Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS Fibrosis Lessens After Metabolic Surgery NCT06374875Phase 422 sites📍 Phoenix📍 Indianapolis📍 Rochester The Cleveland Clinic · Tests: Metabolic surgery, Incretin-Based Therapy
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy